Obstetrx's mission is to eliminate maternal death and disability from postpartum hemorrhage through innovative technology accessible to women worldwide. The company partnered with Oregon Health & Science University to conduct early-stage research and development, culminating in a pre-clinical proof-of-concept study, followed by a pilot clinical trial in Zambia in 2019. Obstetrx is now focused on obtaining regulatory clearance and bringing its novel uterine tamponade device to market, with the goal of saving lives and improving maternal health outcomes around the world.